Leading Life Sciences innovation through structured component authoring
Leading Life Sciences innovation through structured component authoring
Boehringer Ingelheim is a leading research-driven biopharmaceutical company that was growing tired of the inefficiencies of Microsoft Word. As a global organization, they needed a solution that allowed for documents to be created and updated efficiently while enabling flexible and compliant collaboration.
We sat down with Holger Christein, Senior Business Consultant and Senior IT Project Manager at Boehringer Ingelheim to learn how his team discovered Docuvera and why they chose our structured component authoring (SCA) solution to improve their Life Sciences documentation process.
Read this case study to learn more about their experience.
Related Posts
September 25, 2024
AI + Structured Content – A new era of pharmaceutical documentation
When you are alone for days or weeks at…
September 23, 2024
AI + Structured Content – A new era of pharmaceutical documentation
When you are alone for days or weeks at…
November 14, 2023
SCA: The IT-approved Life Sciences solution for content
When you are alone for days or weeks at…